A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson's and other neurodegenerative diseases.
New treatments for glaucoma are a key priority in vision research. Advances in stem cell technology in Cambridge are helping to make this dream a reality.